THE World Health Organization (WHO) is expected to resume evaluation of the Russian coronavirus vaccine soon. Sputnik-V, an official of the international organization assured on Thursday, while the talks with Moscow “are on the verge of being resolved”.
It is recalled that to date, the WHO has approved a small number of vaccines against the new coronavirus, including those of Pfizer/BioNTech, της Modern, της Sinovac and her Sinopharm as well as several versions of those developed by AstraZeneca.
“Sputnik-V started the process (s.s. approval) with the WHO earlier this year and the process was interrupted due to incomplete legal procedures “, stated specifically Dr. Mariangela Simao, Deputy Director of the WHO, responsible for access to medicines and health products. However, he did not specify what those procedures were.
“I am pleased to say that discussions with the Russian government on this issue are close toresolved“, Simao also stressed, as broadcast by AFP.
He then added: “Some information (…) Have yet to be provided, and there are question marks on the finalization of the inspections in the various production centers in Russia, but I am pleased to say that the process is ready to begin “.
It is worth mentioning that Russia is one of the countries in the world where the pandemic has cost more lives – according to worldometers.info the victims of Covid-19 in this country on Thursday night were 213.549.
The population is special suspicious of vaccines produced in Russia and which has been repeatedly promoted by the Kremlin, in particular Sputnik-V, which began to be administered even before the completion of clinical trials, writes also the French Agency.
To this day, and while studies seem to confirm its effectiveness, neither WHERE nor ο EMA and the European Union they have still approved it.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
